V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20048926 | 20086407 | 1.67 | 102.7 | null | 2017-08-21 | 2017-08-21 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100669489 |
| 20048993 | 20086408 | 1.84 | 72.4 | Palliative (P) | null | null | ECarboF | 02 | N | IRINOTECAN | 100973345 |
| 20049019 | 20086409 | 1.59 | 70.2 | 03 | 2019-12-29 | 2020-01-18 | ESPAC-4 TRIAL | 02 | N | DOXORUBICIN | 100368899 |
| 20049050 | 20086410 | 0 | 6.9 | Adjuvant (A) | 2019-09-12 | 2019-09-12 | LENALIDOMIDE | 02 | Y | FLUOROURACIL + RT | 101167184 |
| 20049066 | 20086411 | 1.82 | 71.5 | 03 | 2019-12-17 | 2020-01-01 | null | 02 | N | EOF | 100666119 |
| 20049106 | 20086412 | 1.63 | 85 | 03 | 2018-12-06 | 2018-12-07 | Docetaxel | N | N | CAP + RT | 100467613 |
| 20049132 | 20086413 | 1.66 | null | Neo-adjuvant (N) | 2018-06-03 | 2018-06-03 | ABVD | 01 | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 101053373 |
| 20049182 | 20086415 | 1.62 | 78.9 | Palliative (P) | 2019-04-21 | 2019-04-28 | ACELARATE Trial | 02 | N | OXALIPLATIN | 101060830 |
| 20049186 | 20086416 | 1.7 | 61.3 | 03 | 2019-06-28 | 2019-07-08 | Sunitinib | 02 | N | DARATUMUMAB | 100031699 |
| 20049282 | 20086417 | null | 62 | Palliative (P) | 2017-02-07 | 2017-02-07 | Cape + Cetuximab +Irinotecan - Load | 02 | N | HYDROXYCARBAMIDE | 101109685 |
| 20049346 | 20086418 | 0 | 0 | Palliative (P) | 2018-12-18 | 2018-12-22 | Bevacizumab + Oxaliplatin +MdG | 02 | N | PACLITAXEL | 101149867 |
| 20049395 | 20086419 | null | null | null | 2020-02-01 | 2020-02-18 | Azacitidine | N | Y | DOXORUBICIN + IFOSFAMIDE | 100214849 |
| 20049411 | 20086420 | 1.68 | 49.2 | Palliative (P) | 2017-12-02 | 2017-12-17 | Capecitabine + Streptozocin | 01 | N | SCOPE2 TRIAL | 101279757 |
| 20049515 | 20086421 | 1.77 | 70.3 | 03 | 2019-12-14 | 2019-12-14 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | ESPAC TRIAL | 101543131 |
| 20049518 | 20086422 | 0 | 0 | 03 | 2019-05-11 | 2019-05-25 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | N | IDELALISIB + RITUXIMAB | 100891746 |
| 20049523 | 20086423 | 1.66 | 80.1 | Adjuvant (A) | 2017-04-04 | 2017-04-11 | NAB PACLITAXEL | 01 | N | EOF | 100531478 |
| 20049529 | 20086425 | 0.89 | 49.3 | 03 | 2019-08-22 | 2019-08-22 | ECarboX | 02 | N | CAP + RT | 101465415 |
| 20049542 | 20086426 | 1.62 | 46.3 | null | 2016-11-05 | 2016-11-06 | EVEROLIMUS | 02 | N | EOF | 100708848 |
| 20049586 | 20086427 | 1.86 | 74.2 | null | 2018-12-04 | 2018-12-18 | Azacitidine | 02 | N | IRINOTECAN | 100107531 |
| 20049594 | 20086428 | 1.73 | 102.4 | null | 2018-11-10 | 2018-11-17 | CHLORAMBUCIL + RITUXIMAB | 02 | N | FOXFIRE TRIAL | 101043165 |
| 20049623 | 20086430 | 1.55 | 107.4 | 03 | 2017-10-13 | 2017-10-13 | Irinotecan | 02 | Y | ACTICCA-1 TRIAL | 100270351 |
| 20049667 | 20086432 | 1.58 | 63.4 | Adjuvant (A) | 2019-07-08 | 2019-07-17 | null | 02 | N | CAP + RT | 100395987 |
| 20049670 | 20086433 | 1.58 | 62.65 | null | 2016-12-19 | 2016-12-26 | FCarboSt | 02 | N | ECARBOX | 101170161 |
| 20049792 | 20086434 | 1.66 | 55.8 | Palliative (P) | null | 2017-11-16 | ACELARATE Trial | 01 | N | CAPECITABINE + STREPTOZOCIN | 101466643 |
| 20049816 | 20086435 | 1.7 | 55 | 03 | 2018-08-02 | 2018-08-03 | Irinotecan | Y | N | VEDEX | 100455706 |
| 20049827 | 20086436 | 1.54 | 104 | Neo-adjuvant (N) | 2019-06-29 | 2019-06-29 | CAPE + OXALIPLATIN + TRASTUZUMAB | 01 | N | BENDAMUSTINE + RITUXIMAB | 101595134 |
| 20049869 | 20086437 | 0 | 0 | 03 | 2018-11-27 | 2018-12-19 | ACTICCA-1 Trial | 02 | N | NAB-PACLITAXEL | 101483541 |
| 20049909 | 20086438 | null | null | 03 | 2018-10-29 | 2018-11-27 | EVEROLIMUS | 02 | N | CEMIPLIMAB | 101652621 |
| 20049933 | 20086439 | 1.79 | null | 03 | 2017-12-28 | 2017-12-30 | Cisplatin +FU +Trastuzumab - Load | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100460285 |
| 20049944 | 20086441 | 1.63 | 58.2 | null | null | 2019-02-24 | BEP 3 day | N | N | PACLITAXEL | 101807704 |
| 20049962 | 20086442 | 1.77 | null | Adjuvant (A) | 2020-02-08 | 2020-02-08 | Hydroxycarbamide | 02 | N | FOXTROT TRIAL | 100184105 |
| 20050043 | 20086443 | 1.65 | 76 | 03 | null | 2018-01-03 | CISPLATIN + FLUOROURACIL + RT | 02 | N | OXALIPLATIN | 100345266 |
| 20050086 | 20086444 | 1.62 | 76.8 | Palliative (P) | 2016-12-20 | 2016-12-20 | PEMBROLIZUMAB | 02 | N | PHITT | 101867308 |
| 20050094 | 20086445 | 1.79 | 119.4 | 03 | 2012-03-21 | 2018-07-10 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | Y | RITUXIMAB | 100084467 |
| 20050100 | 20086446 | 1.5 | 83.2 | null | null | 2019-01-28 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FOXTROT TRIAL | 101852885 |
| 20050147 | 20086447 | 1.78 | 79.3 | Palliative (P) | 2019-12-21 | 2020-01-04 | IVE | 2 | N | ACELARATE TRIAL | 100896407 |
| 20050176 | 20086448 | 1.7 | 85 | 03 | 2019-05-20 | 2019-05-20 | Cisplatin + Docetaxel | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 101696326 |
| 20050253 | 20086450 | 1.85 | 73 | Palliative (P) | 2020-08-04 | 2020-08-04 | Rituximab | 2 | N | CYTARABINE | 101484307 |
| 20050259 | 20086451 | 1.66 | 81.3 | Palliative (P) | 2015-08-06 | 2015-08-06 | PANTHER TRIAL | N | N | ECARBOX | 101246287 |
| 20050260 | 20086452 | 1.56 | 64 | 03 | 2019-10-29 | 2019-10-29 | NIVOLUMAB | null | Y | SCOPE2 TRIAL | 101615169 |
| 20050306 | 20086453 | 1.71 | 119.5 | Palliative (P) | 2018-03-24 | 2018-04-21 | PHITT B or C Cisplatin | 02 | N | NAB-PACLITAXEL | 101065912 |
| 20050353 | 20086454 | 1.59 | 72.4 | Adjuvant (A) | 2019-11-23 | 2019-12-03 | MITOMYCIN | 99 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100717557 |
| 20050362 | 20086455 | 1.75 | 58.15 | null | 2018-05-13 | 2018-05-13 | ARISTOTLE TRIAL | 02 | N | IXAZOMIB + LENALIDOMIDE | 100273415 |
| 20050429 | 20086456 | 1.58 | 48 | 03 | 2019-05-16 | 2019-05-16 | OXALIPLATIN | N | N | HEP HR HEPATOBLASTOMA GUIDE CISP | 100792038 |
| 20050435 | 20086457 | 1.67 | null | Palliative (P) | 2016-12-05 | 2016-12-05 | Gemcitabine + Oxaliplatin | 02 | N | PANITUMUMAB | 101578063 |
| 20050442 | 20086458 | 1.67 | 91.4 | Palliative (P) | 2016-10-06 | 2016-10-21 | RUXOLITINIB | 02 | N | LETROZOLE + PALBOCICLIB | 101614459 |
| 20050457 | 20086459 | 1.72 | 63.8 | Palliative (P) | 2020-11-23 | 2020-11-23 | FCiSt | N | N | GO2 TRIAL | 100248698 |
| 20050458 | 20086460 | null | 65 | 03 | null | 2018-10-09 | PEMBROLIZUMAB | null | N | PACLITAXEL | 100410151 |
| 20050472 | 20086461 | 1.79 | 47.5 | Adjuvant (A) | 2020-03-20 | 2020-03-25 | CAP + RT | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 101359421 |
| 20050488 | 20086462 | 1.69 | 79.5 | null | 2017-12-12 | 2018-01-09 | ARISTOTLE TRIAL | N | N | CHLORAMBUCIL | 100181865 |